Correlation Between Johnson Johnson and Curative Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Curative Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Curative Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Curative Biotechnology, you can compare the effects of market volatilities on Johnson Johnson and Curative Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Curative Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Curative Biotechnology.

Diversification Opportunities for Johnson Johnson and Curative Biotechnology

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Johnson and Curative is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Curative Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curative Biotechnology and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Curative Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curative Biotechnology has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Curative Biotechnology go up and down completely randomly.

Pair Corralation between Johnson Johnson and Curative Biotechnology

Considering the 90-day investment horizon Johnson Johnson is expected to generate 619.78 times less return on investment than Curative Biotechnology. But when comparing it to its historical volatility, Johnson Johnson is 80.05 times less risky than Curative Biotechnology. It trades about 0.01 of its potential returns per unit of risk. Curative Biotechnology is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  2.50  in Curative Biotechnology on November 9, 2024 and sell it today you would lose (1.25) from holding Curative Biotechnology or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.74%
ValuesDaily Returns

Johnson Johnson  vs.  Curative Biotechnology

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.
Curative Biotechnology 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Curative Biotechnology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental drivers, Curative Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Johnson Johnson and Curative Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Curative Biotechnology

The main advantage of trading using opposite Johnson Johnson and Curative Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Curative Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curative Biotechnology will offset losses from the drop in Curative Biotechnology's long position.
The idea behind Johnson Johnson and Curative Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements